Find clinical trials for Pancreatic Cancer in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Atlanta, GA, USA:
This is a multi-center clinical study enrolling up to 50 participants. The primary objective of the study is to evaluate the safety of Alpha DaRT in...
Atlanta, Georgia, United States and 14 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Newnan, Georgia, United States and 135 other locations
Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to ...
Phase 3
Atlanta, Georgia, United States and 78 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Atlanta, Georgia, United States and 108 other locations
1) patients with newly diagnosed, advanced, unresectable colorectal cancer (CRC) or 2) patients with newly diagnosed, advanced, unresectable ...
Phase 2
Atlanta, Georgia, United States and 25 other locations
The purpose of this study is to evaluate the efficacy of an investigational RAS(ON) inhibitor administered in combination with chemotherapy compared...
Phase 3
Atlanta, Georgia, United States and 8 other locations
This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, ...
Phase 1, Phase 2
Atlanta, Georgia, United States and 21 other locations
The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.
Phase 3
Atlanta, Georgia, United States and 50 other locations
irinotecan work in treating patients with gastrointestinal cancers that have spread to other places in the body (metastatic) or cannot be re...
Phase 1, Phase 2
Atlanta, Georgia, United States and 2 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.
Phase 3
Atlanta, Georgia, United States and 77 other locations
Clinical trials
Research sites
Resources
Legal